SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2.
Leyun WuLiping ZhouMengxia MoTingting LiuChengkun WuChunye GongKai LuLikun GongJianming ZhuZhijian XuPublished in: Signal transduction and targeted therapy (2022)